Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...

There has been no notable spike in infections in the Capital so far, with just 23 new cases reported over the last 10 days ...

Markets fall as President Trump threatens to increase tariffs on Apple and the European Union. Former Chancellor of the University of North Carolina Chapel Hill Holden Thorp discusses his concerns ...